Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration-Reference-Cited by-同舟云学术

Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration

Published:2014-06 Issue: Volume:56 Page:65-69
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Agersø Henrik,Overgaard Rune Viig,Petersen Mads Bjelke,Hansen Lene,Hermit Mette Brunsgaard,Sørensen Mette Høgh,Petersen Lars Christian,Hilden Ida

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference17 articles.

1. A theoretical model of gamma-globulin catabolism;Brambell;Nature,1964

2. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical, Computing. 2009.

3. Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A;Erhardtsen;Blood Coagul. Fibrinolysis,1995

4. Approximations of the target-mediated drug disposition model and identifiability of model parameters;Gibiansky;J. Pharmacokinet. Pharmacodyn.,2008

5. Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis;Hedner;Annu. Rev. Med.,2008

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring nonreplacement therapies’ impact on hemophilia and other rare bleeding disorders;Research and Practice in Thrombosis and Haemostasis;2024-05

2. Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B;Cochrane Database of Systematic Reviews;2024-02-27

3. Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient’s Perspectives;Journal of Blood Medicine;2022-04

4. Gene Therapy in Hemophilia: Latest Developments;Advances in Hemophilia Treatment;2022

5. Advances in the management of haemophilia: emerging treatments and their mechanisms;Journal of Biomedical Science;2021-09-14